Viewing Study NCT06649656


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2026-01-04 @ 3:47 AM
Study NCT ID: NCT06649656
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-21
First Post: 2024-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors
Sponsor: Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module